{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T10:55:33Z","timestamp":1772103333240,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-38430-w","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T08:46:45Z","timestamp":1770454005000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["In silico discovery of natural compound-derived multi-target inhibitor for Huntington\u2019s disease therapy"],"prefix":"10.1038","volume":"16","author":[{"given":"Bo","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehrukh","family":"Banday","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shalesh","family":"Gangwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid","family":"Raza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,7]]},"reference":[{"issue":"16","key":"38430_CR1","doi-asserted-by":"publisher","first-page":"8363","DOI":"10.3390\/ijms22168363","volume":"22","author":"A Kim","year":"2021","unstructured":"Kim, A. et al. New avenues for the treatment of Huntington\u2019s disease. Int. J. Mol. Sci. 22(16), 8363. https:\/\/doi.org\/10.3390\/ijms22168363 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"38430_CR2","first-page":"10","volume":"8","author":"M Mukhi","year":"2020","unstructured":"Mukhi, M. & Jai, J. Evaluating the potency of three plant compounds as HDAC Inhibitors for the treatment of Huntington\u2019s disease: An in silico study. Int. J. Herbal Med. 8(5), 10\u201313 (2020).","journal-title":"Int. J. Herbal Med."},{"issue":"8","key":"38430_CR3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7759\/cureus.28484","volume":"14","author":"R Andhale","year":"2022","unstructured":"Andhale, R. & Shrivastava, D. Huntington\u2019s disease: A clinical review. Cureus 14(8), 10\u201316. https:\/\/doi.org\/10.7759\/cureus.28484 (2022).","journal-title":"Cureus"},{"issue":"1","key":"38430_CR4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.18295\/2075-0528.2757","volume":"9","author":"EM Scrimgeour","year":"2009","unstructured":"Scrimgeour, E. M. Huntington disease (chorea) in the middle East. Sultan Qaboos. Univ. Med. J. 9(1), 16\u201323 (2009).","journal-title":"Sultan Qaboos. Univ. Med. J."},{"key":"38430_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2025.108080","volume":"141","author":"N Aderinto","year":"2025","unstructured":"Aderinto, N. et al. Prevalence, characteristics, and clinical outcomes of Huntington\u2019s disease in Sub-Saharan Africa: A systematic review and meta-analysis. Parkinsonism. Relat. Disord. 141, 108080. https:\/\/doi.org\/10.1016\/j.parkreldis.2025.108080 (2025).","journal-title":"Parkinsonism. Relat. Disord."},{"issue":"12","key":"38430_CR6","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1002\/mds.29228","volume":"37","author":"A Medina","year":"2022","unstructured":"Medina, A., Mahjoub, Y., Shaver, L. & Pringsheim, T. Prevalence and incidence of Huntington\u2019s disease: An updated systematic review and meta-analysis. Mov. Disord. 37(12), 2327\u20132335. https:\/\/doi.org\/10.1002\/mds.29228 (2022).","journal-title":"Mov. Disord."},{"issue":"3","key":"38430_CR7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s11910-021-01093-3","volume":"21","author":"L Pan","year":"2021","unstructured":"Pan, L. & Feigin, A. Huntington\u2019s disease: New frontiers in therapeutics. Curr. Neurol. Neurosci. Rep. 21(3), 10. https:\/\/doi.org\/10.1007\/s11910-021-01093-3 (2021).","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"2","key":"38430_CR8","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.drudis.2015.11.001","volume":"21","author":"JR Smith","year":"2016","unstructured":"Smith, J. R., Jamie, J. F. & Guillemin, G. J. Kynurenine-3-monooxygenase: A review of structure, mechanism, and inhibitors. Drug. Discov. Today 21(2), 315\u2013324. https:\/\/doi.org\/10.1016\/j.drudis.2015.11.001 (2016).","journal-title":"Drug. Discov. Today"},{"key":"38430_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/fmolb.2019.00003","volume":"6","author":"RS Phillips","year":"2019","unstructured":"Phillips, R. S., Iradukunda, E. C., Hughes, T. & Bowen, J. P. Modulation of enzyme activity in the kynurenine pathway by kynurenine monooxygenase inhibition. Front. Mol. Biosci. 6, 3. https:\/\/doi.org\/10.3389\/fmolb.2019.00003 (2019).","journal-title":"Front. Mol. Biosci."},{"issue":"1","key":"38430_CR10","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3390\/molecules27010273","volume":"27","author":"TD Hughes","year":"2022","unstructured":"Hughes, T. D., G\u00fcner, O. F., Iradukunda, E. C., Phillips, R. S. & Bowen, J. P. The Kynurenine pathway and Kynurenine 3-Monooxygenase inhibitors. Molecules 27(1), 273. https:\/\/doi.org\/10.3390\/molecules27010273 (2022).","journal-title":"Molecules"},{"issue":"1","key":"38430_CR11","doi-asserted-by":"publisher","first-page":"5484","DOI":"10.1038\/s41598-021-84858-7","volume":"11","author":"MK Bondulich","year":"2021","unstructured":"Bondulich, M. K., Fan, Y., Song, Y., Giorgini, F. & Bates, G. P. Ablation of kynurenine 3-monooxygenase rescues plasma inflammatory cytokine levels in the R6\/2 mouse model of Huntington\u2019s disease. Sci. Rep. 11(1), 5484. https:\/\/doi.org\/10.1038\/s41598-021-84858-7 (2021).","journal-title":"Sci. Rep."},{"key":"38430_CR12","doi-asserted-by":"publisher","unstructured":"Kuijper, E. C., Overzier, M., Suidgeest, E., Dzyubachyk, O., Flament, J., Ariyurek, Y., Mei, H., Buijsen, R. A. M., Weerd, L. Van Der, & Roon-mom, W. Van. (2024). Neurobiology of Disease Antisense oligonucleotide-mediated disruption of HTT caspase-6 cleavage site ameliorates the phenotype of YAC128 Huntington disease mice. 190(September 2023). https:\/\/doi.org\/10.1016\/j.nbd.2023.106368","DOI":"10.1016\/j.nbd.2023.106368"},{"issue":"45","key":"38430_CR13","doi-asserted-by":"publisher","first-page":"15019","DOI":"10.1523\/JNEUROSCI.2071-10.2010","volume":"30","author":"RK Graham","year":"2010","unstructured":"Graham, R. K. et al. Cleavage at the 586 amino acid caspase-6 site in mutant huntingtin influences caspase-6 activation in vivo. J. Neurosci. 30(45), 15019\u201315029. https:\/\/doi.org\/10.1523\/JNEUROSCI.2071-10.2010 (2010).","journal-title":"J. Neurosci."},{"issue":"9","key":"38430_CR14","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1093\/hmg\/ddv023","volume":"24","author":"I Aharony","year":"2015","unstructured":"Aharony, I. et al. A Huntingtin-based peptide inhibitor of caspase-6 provides protection from mutant Huntingtin-induced motor and behavioral deficits. Human Mol. Genet. 24(9), 2604\u20132614. https:\/\/doi.org\/10.1093\/hmg\/ddv023 (2015).","journal-title":"Human Mol. Genet."},{"key":"38430_CR15","doi-asserted-by":"publisher","unstructured":"Eldar-finkelman, H., & Martinez, A. (2011). GSK-3 inhibitors\u202f: Preclinical and clinical focus on CNS. 4(October), 1\u201318. https:\/\/doi.org\/10.3389\/fnmol.2011.00032","DOI":"10.3389\/fnmol.2011.00032"},{"key":"38430_CR16","doi-asserted-by":"publisher","unstructured":"Xiong, M. The role of glycogen synthase kinase 3 beta in neurodegenerative diseases. September, 1\u201310. https:\/\/doi.org\/10.3389\/fnmol.2023.1209703. (2023).","DOI":"10.3389\/fnmol.2023.1209703"},{"key":"38430_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2016.07.005","volume":"147","author":"T Jiang","year":"2016","unstructured":"Jiang, T., Sun, Q. & Chen, S. Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson\u2019s disease and Alzheimer\u2019s disease. Prog. Neurobiol. 147, 1\u201319. https:\/\/doi.org\/10.1016\/j.pneurobio.2016.07.005 (2016).","journal-title":"Prog. Neurobiol."},{"key":"38430_CR18","unstructured":"Schr\u00f6dinger. (2025c). Maestro."},{"issue":"1","key":"38430_CR19","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s10753-022-01734-w","volume":"46","author":"D Barh","year":"2023","unstructured":"Barh, D. et al. SARS-CoV-2 variants show a gradual declining pathogenicity and pro-inflammatory Cytokine stimulation, an increasing antigenic and anti-inflammatory Cytokine induction, and rising structural protein instability: A minimal number genome-based approach. Inflammation 46(1), 297\u2013312. https:\/\/doi.org\/10.1007\/s10753-022-01734-w (2023).","journal-title":"Inflammation"},{"issue":"7","key":"38430_CR20","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.1021\/ACS.JCTC.1C00302","volume":"17","author":"C Lu","year":"2021","unstructured":"Lu, C. et al. OPLS4: Improving force field accuracy on challenging regimes of chemical space. J. Chem. Theory Comput. 17(7), 4291\u20134300. https:\/\/doi.org\/10.1021\/ACS.JCTC.1C00302 (2021).","journal-title":"J. Chem. Theory Comput."},{"key":"38430_CR21","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2023.2209673","author":"S Ahmad","year":"2023","unstructured":"Ahmad, S., Singh, V., Gautam, H. K. & Raza, K. Multisampling-based docking reveals Imidazolidinyl urea as a multitargeted inhibitor for lung cancer\u202f: An optimisation followed multi- simulation and in-vitro study inhibitor for lung cancer\u202f: an optimisation followed multi-simulation and in-vitro. J. Biomol. Struct. Dyn. https:\/\/doi.org\/10.1080\/07391102.2023.2209673 (2023).","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"3","key":"38430_CR22","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/S10822-013-9644-8","volume":"27","author":"G Madhavi Sastry","year":"2013","unstructured":"Madhavi Sastry, G., Adzhigirey, M., Day, T., Annabhimoju, R. & Sherman, W. Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments. J. Comput. Aided Mol. Des. 27(3), 221\u2013234. https:\/\/doi.org\/10.1007\/S10822-013-9644-8 (2013).","journal-title":"J. Comput. Aided Mol. Des."},{"key":"38430_CR23","unstructured":"Schr\u00f6dinger. (2025d). Prime."},{"key":"38430_CR24","doi-asserted-by":"publisher","first-page":"111452","DOI":"10.1016\/j.biopha.2021.111452","volume":"138","author":"M Huovinen","year":"2021","unstructured":"Huovinen, M. et al. Biomedicine & pharmacotherapy screening of SIRT6 inhibitors and activators: A novel activator has an impact on breast cancer cells. Biomed. Pharmacother. 138, 111452. https:\/\/doi.org\/10.1016\/j.biopha.2021.111452 (2021).","journal-title":"Biomed. Pharmacother."},{"issue":"7","key":"38430_CR25","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1021\/ct200133y","volume":"7","author":"CR S\u00f8ndergaard","year":"2011","unstructured":"S\u00f8ndergaard, C. R., Olsson, M. H. M., Rostkowski, M. & Jensen, J. H. Improved treatment of ligands and coupling effects in empirical calculation and rationalization of p K a values. J. Chem. Theory Comput. 7(7), 2284\u20132295. https:\/\/doi.org\/10.1021\/ct200133y (2011).","journal-title":"J. Chem. Theory Comput."},{"issue":"8","key":"38430_CR26","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1021\/acs.jctc.3c00044","volume":"19","author":"RC Johnston","year":"2023","unstructured":"Johnston, R. C. et al. Epik: p K a and Protonation State prediction through machine learning. J. Chem. Theory Comput. 19(8), 2380\u20132388. https:\/\/doi.org\/10.1021\/acs.jctc.3c00044 (2023).","journal-title":"J. Chem. Theory Comput."},{"key":"38430_CR27","doi-asserted-by":"publisher","first-page":"e02382","DOI":"10.1016\/j.sciaf.2024.e02382","volume":"26","author":"D Amon","year":"2024","unstructured":"Amon, D. et al. Antimicrobial resistance modifying effects and molecular docking studies of Affinine, derived from Tabernaemontana crassa. Scientif. African 26, e02382. https:\/\/doi.org\/10.1016\/j.sciaf.2024.e02382 (2024).","journal-title":"Scientif. African"},{"key":"38430_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s13321-018-0283-x","author":"J Dong","year":"2018","unstructured":"Dong, J. et al. ADMETlab\u202f: a platform for systematic ADMET evaluation based on a comprehensively collected ADMET database. J. Cheminformatics https:\/\/doi.org\/10.1186\/s13321-018-0283-x (2018).","journal-title":"J. Cheminformatics"},{"key":"38430_CR29","unstructured":"Schr\u00f6dinger. (2025e). QikProp."},{"issue":"18","key":"38430_CR30","doi-asserted-by":"publisher","first-page":"4331","DOI":"10.3390\/ijms20184331","volume":"20","author":"L Pinzi","year":"2019","unstructured":"Pinzi, L. & Rastelli, G. Molecular docking: Shifting paradigms in drug discovery. Int. J. Mol. Sci. 20(18), 4331. https:\/\/doi.org\/10.3390\/ijms20184331 (2019).","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"38430_CR31","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1021\/JM030644S","volume":"47","author":"TA Halgren","year":"2004","unstructured":"Halgren, T. A. et al. Glide: A new approach for rapid, accurate docking and scoring 2 enrichment factors in database screening. J. Med. Chem. 47(7), 1750\u20131759. https:\/\/doi.org\/10.1021\/JM030644S (2004).","journal-title":"J. Med. Chem."},{"key":"38430_CR32","unstructured":"Schr\u00f6dinger. (2025a). Glide."},{"issue":"21","key":"38430_CR33","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.1021\/JM051256O","volume":"49","author":"RA Friesner","year":"2006","unstructured":"Friesner, R. A. et al. Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J. Med. Chem. 49(21), 6177\u20136196. https:\/\/doi.org\/10.1021\/JM051256O (2006).","journal-title":"J. Med. Chem."},{"key":"38430_CR34","unstructured":"D. E. Shaw Research. (2024). Desmond molecular dynamics system."},{"key":"38430_CR35","unstructured":"Schr\u00f6dinger. (2025b). Maestro-desmond interoperability tools."},{"issue":"1","key":"38430_CR36","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1080\/00268977200100031","volume":"23","author":"IR McDonald","year":"1972","unstructured":"McDonald, I. R. NpT -ensemble Monte Carlo calculations for binary liquid mixtures. Mol. Phys. 23(1), 41\u201358. https:\/\/doi.org\/10.1080\/00268977200100031 (1972).","journal-title":"Mol. Phys."},{"key":"38430_CR37","doi-asserted-by":"publisher","first-page":"8843954","DOI":"10.1155\/2024\/8843954","volume":"2024","author":"P Manu","year":"2024","unstructured":"Manu, P., Nketia, P. B., Osei-Poku, P. & Kwarteng, A. Computational mutagenesis and inhibition of staphylococcus aureus AgrA LytTR domain using Phenazine Scaffolds: Insight from a biophysical study. Biomed. Res. Int. 2024, 8843954. https:\/\/doi.org\/10.1155\/2024\/8843954 (2024).","journal-title":"Biomed. Res. Int."},{"key":"38430_CR38","unstructured":"Schr\u00f6dinger. (2025f). WaterMap."},{"issue":"6","key":"38430_CR39","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1021\/JA00214A001","volume":"110","author":"WL Jorgensen","year":"1988","unstructured":"Jorgensen, W. L. & Tirado-Rives, J. The OPLS potential functions for proteins. Energy minimizations for crystals of cyclic peptides and Crambin. J. Am. Chem. Soc. 110(6), 1657\u20131666. https:\/\/doi.org\/10.1021\/JA00214A001 (1988).","journal-title":"J. Am. Chem. Soc."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38430-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38430-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38430-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T09:55:29Z","timestamp":1772099729000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38430-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,7]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["38430"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-38430-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,7]]},"assertion":[{"value":"26 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"7716"}}